beginning distribution across the world

KSX has made some excellent progress on its wheez-o-meter. Today's announcement is once again very material. In particular this part:

and expand the Company?s presence to about 55% of US medical providers. The US subsidiary expects to have coverage across the entire United States within six months.

55% of ALL medical providers and expecting to have 100% coverage across the US within 6 months. This on top of the CE approval just the other day paving the way for KSX to market the WHOlter device across Europe as well.

This has to be re-rated from here. Currently has a marketcap of just $20mill. Once sales start showing up on the bottom line this is going to prove very cheap.